Torrens L, Montironi C, Puigvehi M, Mesropian A, et al. Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma. Hepatology 2021 Jun 22. doi: 10.1002/hep.32023.
PMID: 34157147